Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMB vs GSK✓SelectedUSD · GSKWMB vs GSK performance historyLatest closeAs of-2.75%11/20
Stock and ETF performance explorer

WMB vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+250.6%
GSK return
+97.4%
Excess return
+153.1%
Maximum drawdown
-68.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-2.8%-0.1%-2.6%-2.7%
7D-6.9%-5.3%-1.6%-5.6%
30D-11.7%-3.7%-8.0%-11.0%
3M-9.6%-7.3%-2.4%-8.2%
6M-16.2%-4.2%-12.0%-16.0%
YTD+9.3%+0.9%+8.5%+7.1%
1Y+12.5%+7.3%+5.2%+8.0%
3Y+102.0%+52.7%+49.3%+64.9%
5Y+192.2%+40.1%+152.1%+141.5%
All+250.6%+97.4%+153.1%+149.1%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling